Rising Stars of Life Sciences: Driving Innovation in Healthcare

Celebrating Breakthroughs in 2024

The 2024 Rising Stars, recognized at the iC³ Life Science Summit, showcased groundbreaking achievements in life sciences and healthcare innovation. These innovators are driving progress in biotech, healthcare, and life sciences industries.

Almaden Genomics, CorInnova, GenrAb, Island Pharmaceuticals, Opsin Biotherapeutics, Panthera BioSolutions, SingleCell Biotechnology, and Solenic Medical are just a few examples of these remarkable companies. Their groundbreaking work spans from accelerated genomic analysis to precision tools for single-cell research.

"The achievements of the Rising Stars continue to inspire," said Logan Atkins, Financial Advisor at Morgan Stanley. "Their unwavering mission is to raise the standard of care, and we're proud to support their journey."

Legacy of Innovation

Since its inception, the Rising Stars program has honored innovators who have significantly shaped the industry. Past recipients include Eosera, Colossal Biosciences, and Osteal Therapeutics, all known for their pioneering contributions.

"The Rising Stars are a testament to the talent and determination in North Texas," said Kathleen Otto, CEO of BioNTX. "Their successes pave the way for future innovators."

Call for Nominations: 2025 Rising Stars

Nominations are now open for the 2025 Rising Stars. Eligible nominees include entrepreneurs, innovative startups, researchers, and scientists driving transformation and impact in life sciences through innovation and ingenuity. To submit a nomination, visit the Rising Star page.

About the iC³ Life Science Summit

The iC³ Life Science Summit connects leaders, innovators, and stakeholders in the life sciences and healthcare industries. It fosters dialogue, collaboration, and recognition, empowering the industry to address challenges and drive progress.